This bottleneck can be arrested if clinicians understand the limitations of some
therapies currently in use. Secondary failure arises as a
result of deteriorating beta cell function, poor
compliance to treatment, weight gain, reduced exercise,
dietary changes, or illness. A major drawback
associated with hypoglycemic agents is that they are
expensive and harbor adverse effects on patients
Plant derived medications have also found immense use
in the management of diabetes mellitus